The report trims the target to Rs 400 from Rs 420 while maintaining ADD, expecting 10.4% YoY revenue growth on a low base.
Read this note →Relaxo Footwears Limited
NSE RELAXO BSE 530517 INE131B01039
0 filings · 0 analysed
290.70
-32.87%
over 5 years
-
Consumer Discretionary 2QFY27 Results Preview HSIE
The report trims the target to Rs 400 from Rs 420 while maintaining ADD, expecting 10.4% YoY revenue growth on a low base.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 10 Oct 2026, 07:45 | long | 286.00 | 400.00 | 292.10 | 5% | open by 2027-10-10 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief